The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

2021 Virtual KU Hematology and Medical Oncology Review
A

2021 KUMC NDMM Updates: Assessing Current Trials for Treatment, Induction Therapy, and Role of HDCT/ASCT in Clinical Practice

By 2021 Virtual KU Hematology and Medical Oncology Review FEATURING Al-Ola Abdallah
By 2021 Virtual KU Hematology and Medical Oncology Review FEATURING Al-Ola Abdallah
0 views
July 22, 2021
Comments 1
Login to view comments. Click here to Login

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Featured Video

06:27
Johnson & Johnson

Challenges to Navigate in Locally Advanced or Metastatic EGFR+ NSCLC

Feat. M. Socinski, D. Waterhouse
2021 Virtual KU Hematology and Medical Oncology Review
43:11
2021 Virtual KU Hematology and Medical Oncology Review

2021 Advances in Metastatic Sarcoma: GIST & Ripretinib, Synovial…

Feat. B. Van Tine
25:06
2021 Virtual KU Hematology and Medical Oncology Review

ASCO 2021 Survivorship Highlights: Remote Symptom Monitoring, Inpati…

Feat. E. Wulff-Burchfield
30:04
2021 Virtual KU Hematology and Medical Oncology Review

2021 Updates in HNSCC: Expert Overview of Recent Clinical Trials

Feat. B. Burtness
09:13
2021 Virtual KU Hematology and Medical Oncology Review

ASCO 2021 Updates in Head and Neck Cancers: Advanced NPC, HPV-Relate…

Feat. B. Burtness
18:15
2021 Virtual KU Hematology and Medical Oncology Review

KUMC Highlights on mCRC: Recent Data on Changes in the SoC

Feat. W. Sun
06:25
2021 Virtual KU Hematology and Medical Oncology Review

2021 KUMC Metastatic Prostate Cancer Updates: 177Lu-PSMA-617 in mCRP…

Feat. S. Abbasi
08:08
2021 Virtual KU Hematology and Medical Oncology Review

2021 Developments in RCC & UC: Pembro for ccRCC, Sacituzumab Gov…

Feat. S. Abbasi
15:17
2021 Virtual KU Hematology and Medical Oncology Review

2021 Advances in CML: Prognostic Scores, Treatment Goals, 1L & B…

Feat. A. Yacoub
05:01
2021 Virtual KU Hematology and Medical Oncology Review

2021 Advances in Myelofibrosis: Parsaclisib + Ruxolitinib Combinatio…

Feat. A. Yacoub
10:52
2021 Virtual KU Hematology and Medical Oncology Review

2021 KUMC NDMM Updates: Assessing Current Trials for Treatment, Indu…

Feat. A. Abdallah
07:17
2021 Virtual KU Hematology and Medical Oncology Review

2021 KUMC Updates on Triple R/R MM: Does Ide-Cel Improve Overall Res…

Feat. A. Abdallah
27:42
2021 Virtual KU Hematology and Medical Oncology Review

CAR T-Cell and CRISPR in Hematologic Malignancies: Continuing Revolu…

Feat. J. McGuirk
10:44
2021 Virtual KU Hematology and Medical Oncology Review

ASCO 2021 Highlights on TNBC: Durvalumab + Neoadjuvant Therapy in Ea…

Feat. Q. Khan
08:59
2021 Virtual KU Hematology and Medical Oncology Review

ASCO 2021 Review of the OlympiA Trial for High-Risk EBC: Do Adjuvant…

Feat. Q. Khan
10:17
2021 Virtual KU Hematology and Medical Oncology Review

ASCO 2021 Updates on De-Escalation Strategies in BC: Talazoparib for…

Feat. Q. Khan